Literature DB >> 18083463

Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis.

Jørn Wetterslev1, Kristian Thorlund, Jesper Brok, Christian Gluud.   

Abstract

BACKGROUND AND
OBJECTIVE: Cumulative meta-analyses are prone to produce spurious P<0.05 because of repeated testing of significance as trial data accumulate. Information size in a meta-analysis should at least equal the sample size of an adequately powered trial. Trial sequential analysis (TSA) corresponds to group sequential analysis of a single trial and may be applied to meta-analysis to evaluate the evidence. STUDY DESIGN AND
SETTING: Six randomly selected neonatal meta-analyses with at least five trials reporting a binary outcome were examined. Low-bias heterogeneity-adjusted information size and information size determined from an assumed intervention effect of 15% were calculated. These were used for constructing trial sequential monitoring boundaries. We assessed the cumulative z-curves' crossing of P=0.05 and the boundaries.
RESULTS: Five meta-analyses showed early potentially spurious P<0.05 values. In three significant meta-analyses the cumulative z-curves crossed both boundaries, establishing firm evidence of an intervention effect. In two nonsignificant meta-analyses the cumulative z-curves crossed P=0.05, but never the boundaries, demonstrating early potentially spurious P<0.05 values. In one nonsignificant meta-analysis the cumulative z-curves never crossed P=0.05 or the boundaries.
CONCLUSION: TSAs may establish when firm evidence is reached in meta-analysis.

Mesh:

Year:  2007        PMID: 18083463     DOI: 10.1016/j.jclinepi.2007.03.013

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  508 in total

1.  Ethical issues in surgical research.

Authors:  Patrick J McDonald; Abhaya V Kulkarni; Forough Farrokhyar; Mohit Bhandari
Journal:  Can J Surg       Date:  2010-04       Impact factor: 2.089

Review 2.  Nutritional support for liver disease.

Authors:  Ronald L Koretz; Alison Avenell; Timothy O Lipman
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

Review 3.  Patient-controlled analgesia with remifentanil versus alternative parenteral methods for pain management in labour.

Authors:  Stephanie Weibel; Yvonne Jelting; Arash Afshari; Nathan Leon Pace; Leopold Hj Eberhart; Johanna Jokinen; Thorsten Artmann; Peter Kranke
Journal:  Cochrane Database Syst Rev       Date:  2017-04-13

4.  Band ligation versus no intervention for primary prevention of upper gastrointestinal bleeding in adults with cirrhosis and oesophageal varices.

Authors:  Sonam Vadera; Charles Wei Kit Yong; Lise Lotte Gluud; Marsha Y Morgan
Journal:  Cochrane Database Syst Rev       Date:  2019-06-20

5.  Erythropoietin in patients with acute myocardial infarction: no proof of effectiveness or proof of no effectiveness?

Authors:  Andrea Messori; Valeria Fadda; Dario Maratea; Sabrina Trippoli
Journal:  Clin Cardiol       Date:  2013-08-08       Impact factor: 2.882

Review 6.  Branched-chain amino acids for people with hepatic encephalopathy.

Authors:  Lise Lotte Gluud; Gitte Dam; Iñigo Les; Giulio Marchesini; Mette Borre; Niels Kristian Aagaard; Hendrik Vilstrup
Journal:  Cochrane Database Syst Rev       Date:  2017-05-18

Review 7.  Avoidance versus use of neuromuscular blocking agents for improving conditions during tracheal intubation or direct laryngoscopy in adults and adolescents.

Authors:  Lars H Lundstrøm; Christophe Hv Duez; Anders K Nørskov; Charlotte V Rosenstock; Jakob L Thomsen; Ann Merete Møller; Søren Strande; Jørn Wetterslev
Journal:  Cochrane Database Syst Rev       Date:  2017-05-17

8.  Genetic Variant Arg399Gln G>A of XRCC1 DNA Repair Gene Enhanced Cancer Risk Among Indian Population: Evidence from Meta-analysis and Trial Sequence Analyses.

Authors:  Raju K Mandal; Rama D Mittal
Journal:  Indian J Clin Biochem       Date:  2017-07-10

9.  Surgical portosystemic shunts versus devascularisation procedures for prevention of variceal rebleeding in people with hepatosplenic schistosomiasis.

Authors:  Chikwendu J Ede; Dimitrinka Nikolova; Martin Brand
Journal:  Cochrane Database Syst Rev       Date:  2018-08-03

Review 10.  Transarterial chemoembolization combined with sorafenib for unresectable hepatocellular carcinoma: a systematic review and meta-analysis.

Authors:  Man Yang; Jin-Qiu Yuan; Ming Bai; Guo-Hong Han
Journal:  Mol Biol Rep       Date:  2014-08-05       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.